Skip to main content
. 2024 Jul 6;23:202. doi: 10.1186/s12936-024-05031-9

Table 1.

Follow up days

S. no Procedures D 0 D 1 D 2 D 3 D 7 D 14 D 21 D 28 D 35 D 42 Extra day
Adverse event X X X X X X X X X X
1 Temperature X X X X X X X X X X
2 BF(asexual parasites count) X X X X X X X X X X
3 Gametocyte count X X X X X X X X X X
4 Hemoglobin X X X X
5 DBS X X TF TF TF TF TF TF
6 CQ treatment X X X
7 PQ treatment X X X X(3) X(6)
8 Urine/hill men X X X X X X
9 Treatment outcome